Navigation Links
OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
Date:8/30/2007

Private offering provides new funding as OncoVista, Inc. takes steps

towards public reporting status.

SAN ANTONIO, Aug. 30 /PRNewswire/ -- OncoVista, Inc., a biopharmaceutical company engaged in the development and commercialization of targeted cancer therapies with improved efficacy and reduced toxicity, announced the successful completion of a private placement offering and its acquisition of a control position in a public reporting shell company.

OncoVista completed the private sale of 970,712 units of common stock and warrants to new and existing investors raising approximately $6.8 million in gross proceeds. Participants in the offering included Wexford Capital LLC, CAMOFI Master LDC, Bristol Investment Fund, Ltd., as well as other select institutional and qualified investors. Maxim Group, LLC acted as the company's exclusive placement agent in the offering. Contemporaneously with the closing, OncoVista acquired a control position in Aviation Upgrade Technologies, Inc., a Nevada corporation (OTC Bulletin Board: AVUG) and transferred the former operating subsidiary to its former chief executive officer.

"The closing of our financing and our acquisition of a public reporting company in preparation for our becoming a publicly-traded company marks a very exciting and important milestone in OncoVista's history," said Alexander L. Weis, Ph.D., Chairman of the Board of Directors, President and Chief Executive Officer of OncoVista, Inc. "Targeted oncology therapy is an attractive and growing business segment, and our ability to access the public capital market is a tremendous opportunity for further growth of OncoVista," Dr. Weis said.

About OncoVista, Inc.

A biopharmaceutical company engaged in the development and commercialization of targeted cancer therapies both through the acquisition of rights to technologies and drugs from others and through the development of proprietary products. OncoVista intends t
'/>"/>

SOURCE OncoVista, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NimbleGen closes $8.2m venture round, bringing total to $50m
2. BoneCare doubles options and profits as fiscal year closes
3. DEMO 2003 Closes with Focus on Collaboration and Communication
4. Venture Investors early-stage fund grows to $115 million
5. Two convicted of selling $6 million in counterfeit Rockwell software on eBay
6. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
7. TomoTherapy raises $223 million in IPO
8. Fiserv reports $113.5 million in Q1 profit
9. Investors raise $25 million for biodiesel plant
10. Grow Milwaukee includes millions for tech funding
11. Mirus Bio, Pfizer enter multimillion-dollar research agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomoreprest...ion,sleadingonlinejobboardandcareerssiteforlifesci...iversityarenowmembersofthejobboard,joining28otherm...oard, www.biocareercenter.com ,isonlyforpost-gradu...ciencecareersitesontheInternet,BioCareerCenteristh...
(Date:11/24/2009)... REYKJAVIK,Iceland,November24/PRNewswire-FirstCall...edthatithasreceivednoticefrom,theNasdaqStockMarket...edasofNovember30,2009andaForm25-NSEwillbefiledwith...edeCODE,scommonstock,fromlistingonNasdaq,unlessthe...onsPanel.Thecompanyhasfiledsuchanappeal,which,will...
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceutic...TO)hasallowedthepatentapplicationfor,itsnano-parti...gyisahighlyefficientapproachtoincorporatepeptideso...aldeliveryofdrugs,otherwiseadministeredasinjection...iedtomanymacromoleculardrugssuchasinsulin,interfer...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... Identify Patients At Risk of Heart ..., Aug. 12 Atherotech, Inc., a,cardio-diagnostic c...nsurers in Florida as well as Medicare, Medicaid a...ogram now cover the VAP(R) (Vertical Auto Profile)...ilable. That means 9,million more insured lives in...
...wire-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ), a ...on,researching, developing, manufacturing and mark...its unaudited financial results for the second,qua...inancial Highlights: -- Total net revenues increa...9.6 million (US$8.7 million). -- Net revenue from...
...atients from,being unwitting victims in the prolif...epair Stem Cell Institute LLC (RSCI),( http://www....Board (SAB),today announced the establishment of t...pair Stem Cells(TM) (RSC) treatment centers worldw...lls. Among the critical ethical,criteria, which ar...
Other Biology Technology:VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured 23SBio Inc. Announces Second Quarter 2008 Results 23SBio Inc. Announces Second Quarter 2008 Results 33SBio Inc. Announces Second Quarter 2008 Results 43SBio Inc. Announces Second Quarter 2008 Results 53SBio Inc. Announces Second Quarter 2008 Results 63SBio Inc. Announces Second Quarter 2008 Results 73SBio Inc. Announces Second Quarter 2008 Results 83SBio Inc. Announces Second Quarter 2008 Results 93SBio Inc. Announces Second Quarter 2008 Results 103SBio Inc. Announces Second Quarter 2008 Results 113SBio Inc. Announces Second Quarter 2008 Results 123SBio Inc. Announces Second Quarter 2008 Results 133SBio Inc. Announces Second Quarter 2008 Results 143SBio Inc. Announces Second Quarter 2008 Results 15Repair Stem Cell Institute Announces Industry's First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics 2
(Date:11/24/2009)...tanding how sounds associated with Navy sonar migh...y hear it at all. , The same type of large indus...t flaws in the space shuttle,s behemoth solid fuel... the giant head of a whale. The scans are providin... hearing anatomy using a breakthrough method devel...
(Date:11/24/2009)...-- The Wildlife Conservation Society (WCS) announc...g population of Siberian tigers has likely decline... and habitat loss. , WCS says the re...eds to be done to protect remaining populations of...ort was released by the Siberian Tiger Monitoring ...
(Date:11/23/2009)...ce that the "synergistic" effect of early-life exp...d indoor endotoxin causes more harm to developing ...Environmental health scientists at the University ...that children exposed to both high levels of traff...arly life are six times more likely to experience ...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Older People at Greater Risk of Swine Flu Death 61188 1Older People at Greater Risk of Swine Flu Death 61188 2Surgery Not Always Best for Narrowed Kidney Arteries 61185 1Surgery Not Always Best for Narrowed Kidney Arteries 61185 2Surgery Not Always Best for Narrowed Kidney Arteries 61185 3GettingHired com Recognizes First Year Anniversary Renews Commitment to Helping Lead the Effort to Reduce Employment Participation Gap for People wit 61181 1GettingHired com Recognizes First Year Anniversary Renews Commitment to Helping Lead the Effort to Reduce Employment Participation Gap for People wit 61181 2GettingHired com Recognizes First Year Anniversary Renews Commitment to Helping Lead the Effort to Reduce Employment Participation Gap for People wit 61181 3
...rs at the University of Illinois at Chicago shows ...sible for severe acute respiratory syndrome, or SA... agents or vaccines for SARS, which killed almost ...asis of their success, the researchers have receiv... of Allergy and Infectious Diseases to develop pro...
...n in the body, a virus such as HIV invades body ce...uter membrane. Once inside the cell, the invading ... ,host, cell into a factory to produce more copies...r cells in the body. , Scientists had assumed that..., infection of the host cell was inevitable. Thus,...
...solution reduces allergenic properties of moldRese...nter have demonstrated that dilute bleach not only...ize the mold allergens that cause most mold-relate...eptember issue of The Journal of Allergy and Clini... allergic individuals of mold spores treated with ...
Other Biology News:UIC developing drug for SARS 2UIC developing drug for SARS 3Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 2Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 3Bleach found to neutralize mold allergens 2
Yeast tRNA 50 l from BD Biosciences Pharmingen
Guanosine 5′-O-(2-Thiodiphosphate), Trilithium Salt from Calbiochem
...l for reducing sample and waste volumes in DNA seq...ght-channel nano25 delivers with performance and p...: , Real-time documented confirmation of all aspir... detect and correct clogging, adapt to liquids tem...
...solation of DNA from high melt agarose. Simply pla...ge for 3 minutes, and the majority of your DNA is ... any special buffers. Spin filters can also be us...actions, and removal of excess label.,Your satis...
Biology Products: